当前位置: X-MOL 学术Cancer Cell › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Loss or Inhibition of Stromal-Derived PlGF Prolongs Survival of Mice with Imatinib-Resistant Bcr-Abl1+ Leukemia.
Cancer Cell ( IF 48.8 ) Pub Date : 2020-01-13 , DOI: 10.1016/j.ccell.2019.12.010
Thomas Schmidt , Behzad Kharabi Masouleh , Sonja Loges , Sandra Cauwenberghs , Peter Fraisl , Christa Maes , Bart Jonckx , Kim De Keersmaecker , Maria Kleppe , Marc Tjwa , Thomas Schenk , Stefan Vinckier , Rita Fragoso , Maria De Mol , Karolien Beel , Sérgio Dias , Catherine Verfaillie , Richard E Clark , Tim H Brümmendorf , Peter Vandenberghe , Shahin Rafii , Tessa Holyoake , Andreas Hochhaus , Jan Cools , Michael Karin , Geert Carmeliet , Mieke Dewerchin , Peter Carmeliet



中文翻译:

伊马替尼耐药的Bcr-Abl1 +白血病的基质细胞衍生PlGF的丧失或抑制可延长小鼠的存活率。

更新日期:2020-01-13
down
wechat
bug